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tion of effect was calculated to explain the potential mediating effect of leisure
physical activity on the relationship between occupational social categories and
CVD. 
Results The incidence rates were respectively for: Hard CVD (2.4%), myo-
cardial infarction (2.2%), angina (3.4%), coronary death (0.4%), total heart
events (5.7%) and stroke (1.1%). Employees and manual workers have signifi-
cant higher risks of hard cardiovascular events, myocardial infarction and total
heart events compared with white collar, in crude analysis (HR≈1.5). Adjust-
ments for classical cardiovascular factors reduced significantly these risks while
a weak impact of leisure physical activity on the relationships between occupa-
tional categories and each event was highlighted. 
Conclusion The cardiovascular gradient observed between the different
occupational categories is mainly explained by classical cardiovascular factors.
Leisure physical activity is not sufficient by itself to compensate the occupa-
tional social inequalities. 
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Background A population-based incidence estimates of Sudden Cardiac
Death (SCD) in sub-Saharan Africa (SSA) is unknown. We sought to deter-
mine the epidemiology of SCD in Douala, Cameroon. 
Method and results During 12 months, 4 districts were randomly chosen
to monitor all deaths. The COSA ("comité de santé") of each area registered
every death, and a postgraduate fellow recorded detailed demographic and
medical data for victims of natural death. A senior physician studied every
case of suspected sudden death, either cardiac or extra-cardiac. For optimal
exhaustiveness, surrounding hospital mortuaries were checked simultaneously
to match identities of victims. Established SCD was defined as rapid wit-
nessed collapses leading to death within 1h after the onset of symptoms, and
probable SCD as unexpected death within 24h without obvious extra-cardiac
cause. Our registry numbered 240 000 people and 2304 deaths. The overall
mortality rate was 11.2/1000 inhabitants/year. Four (0.3%) were sudden extra-
cardiac death, and 58 (2.5%) SCD of which 41.4% were established and
48.3% had <40 year-old. The incidence rate of SCD was 24.2/100 000 person-
year. Coronary artery disease or dilated cardiomyopathy was able to be diag-
nosed in 13.8% cases. Out-of-hospital cardiac arrest (OHCA) occurred in
58.6% victims, of which 35.3% at home, and 58.8% in a cab, on the way
towards hospital. Witness cardiac arrest was reported in 86.2% cases, but only
7.4% of victims experienced cardiopulmonary resuscitation attempts. 
Conclusion Although not negligible, the SCD incidence in this SSA
population is lower than that reported in most of western countries. However,
as the vast majority of cases are witnessed cardiac arrests, the absence of CPR
attempts raises the question of educating populations in providing basic life
support rescue to tackle this potential reversible fatal outcome.
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Introduction Care pathways are quickly developing involving hospital and
out-of hospital cares for patients with heart failure (HF). To improve the clin-
ical managment and optimize the insurance economics, we aimed at decribing
the care pathways and the consistency with clinical status and care access.
Methods A retrospective cohort of patients living in the French region
Languedoc-Roussillon was built. Inclusion criteria were mainly: first admis-
sion for HF in 2012; follow-up more than 1 year. The database we used (the
SNIIRAM) include outpatient care claim data and hospitalization data.
Patients were classified by a hierarchical ascending classification on principal
components, using variables describing clinical status, use of specialized and
non-specialized care, and main clinical outcomes (hospitalization, death).
Results 2751 patients were included and followed during a median of
22 months. Mean age was 78, 484 (18%) died, 818 (30%) were readmitted at
least once for heart failure. The cluster analysis revealed three different signif-
icant groups: 1/ group 1 (N=734) is characterized by a younger age, more
cares with cardiologists and less main clinical outcomes. Groups 2 and 3 are
not different as regards age and comorbidities. 2/group 2 (N=1060) differs
from the group 3 (N=957): less cares out-of the hospital contrasting with more
cares at hospital, especially at emergencies.
Conclusion This cohort enables to evaluate consistency and adequation
between cares and clinical status, following mail clinical outcomes. As this
cohort is built in a heterogeneous region in terms of medical density or health
organization, it should be a powerful tool for the study of spatial determinants.
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Objective of the study is to provide descriptive statistics on patterns of pra-
sugrel usage in outpatient settings in France. The aim was to observe if the
guidance for the use of Prasugrel from the European label was respected.
Methods This retrospective study was conducted to describe treatment pat-
terns of prasugrel in outpatient settings in France using the IMS Disease Ana-
lyzer database, which collects electronic medical records of patients followed
by a national representative of 1200 French general practitioners (GPs). Anon-
ymous data are collected prospectively and continuously during each follow-
up visit. The study population consisted of patients who had at least 1 pre-
scription of prasugrel in outsetting starting from launch to 3 years post launch.
The patients were followed from the date of the first prasugrel prescription
recorded in the data base (index date) until they died, changed of GP or
reached the end of the study, whichever came first. 
Results In France, the IMS Disease Analyzer included 1.052 patients
receiving at least one prescription of prasugrel from January 2010 until
October 2012. 85% (n=894) were male (n=894), the mean age was 58.5 years.
5.7% of patients were aged more than 75 years, and 5.0% weighed 60kg or
less. Only 0.2% (n=2) had a history of TIA/stroke among this cohort.
Prasugrel was prescribed at a daily maintenance dose of 10mg for 99.8%
of patients (1.050 patients). Concomitant medications were usual (aspirin,
lipid lowering agents, beta blockers, angiotensin-converting-enzyme (ACE)-
inhibitors. 55.1% of patients received an anti-ulcer medication (mainly Proton
Pump Inhibitor [PPI). The persistence with prasugrel using the MPR (Medica-
tion Possession Ratio) was respectively 60.7% and 63.2% for patients with at
6 months (n=504) and 12 months follow-up (n=213). 13.7% of patients were
switched from another thienopyridine (primarily clopidogrel). 
Conclusion In prasugrel-treated patients, respect of Prasugrel indications
was highly fulfilled. Almost all patients received aspirin combined to prasu-
grel. Of note, half of patients were treated with an anti-ulcer medication. The
main results reflect a good usage of prasugrel by French GPs, in collaboration
with cardiologists, with a satisfying understanding and implementation of the
European label, in contrast with recent American registry’s findings.
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